Bangkok Genomics Innovation PCL (BKK:BKGI) Quick Ratio: 4.29 (As of Dec. 2025) — Near Median


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.10
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL Quick Ratio?

Bangkok Genomics Innovation PCL BKK:BKGI +3.96% 45 Quick Ratio is 4.29 as of Dec. 2025, which is at its 10-year median of 4.29. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 82.33% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Bangkok Genomics Innovation PCL's quick ratio for the quarter that ended in Dec. 2025 was 4.29.

Bangkok Genomics Innovation PCL has a quick ratio of 4.29. It generally indicates good short-term financial strength.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's Quick Ratio or its related term are showing as below:

BKK:BKGI' s Quick Ratio Range Over the Past 10 Years
Min: 0.84   Med: 4.29   Max: 10.79
Current: 4.29

During the past 7 years, Bangkok Genomics Innovation PCL's highest Quick Ratio was 10.79. The lowest was 0.84. And the median was 4.29.

BKK:BKGI's Quick Ratio is ranked better than
82.33% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.73 vs BKK:BKGI: 4.29

Bangkok Genomics Innovation PCL  (BKK:BKGI) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Bangkok Genomics Innovation PCL Quick Ratio Related Terms


Bangkok Genomics Innovation PCL Quick Ratio Historical Data

* Premium members only.

The historical data trend for Bangkok Genomics Innovation PCL's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Genomics Innovation PCL Quick Ratio Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial 4.09 7.94 5.68 10.79 4.29

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.79 11.06 9.32 6.26 4.29

BKK:BKGI vs TMO, DHR, IDXX: Quick Ratio Comparison

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's Quick Ratio falls into.


BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Bangkok Genomics Innovation PCL's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(580.355-36.085)/126.824
=4.29

Bangkok Genomics Innovation PCL's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(580.355-36.085)/126.824
=4.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 4.29 mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Quick Ratio of 4.29 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is near median its historical median of 4.29. Over the past decade, Bangkok Genomics Innovation PCL's Quick Ratio has ranged from 0.84 to 10.79. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #38 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 17.7%.
Is Bangkok Genomics Innovation PCL's Quick Ratio too high?
Bangkok Genomics Innovation PCL's current Quick Ratio of 4.29 is near median its 10-year median of 4.29. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 10.79. The Medical Diagnostics & Research industry median Quick Ratio is 1.73. Bangkok Genomics Innovation PCL's value of 4.29 is 148% above this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #38 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #38 out of 215 companies for Quick Ratio. This places Bangkok Genomics Innovation PCL in the top 18% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.73. Bangkok Genomics Innovation PCL's value of 4.29 is 148% above this benchmark. Historically, Bangkok Genomics Innovation PCL's own Quick Ratio has ranged from 0.84 to 10.79 over the past decade. While the company's 10-year median is 4.29 vs. the industry median of 1.73, Bangkok Genomics Innovation PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.73, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Quick Ratio of 4.29 is 148% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Quick Ratio is 4.29, which is near median its own 10-year median of 4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Quick Ratio of 4.29. The current Quick Ratio is 4.29, which is near median its 10-year median of 4.29 and 148% above the Medical Diagnostics & Research industry median of 1.73. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Quick Ratio is 4.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.10
Price